Prevalence of post-acute COVID-19 symptoms ...
Type de document :
Article dans une revue scientifique: Article original
PMID :
URL permanente :
Titre :
Prevalence of post-acute COVID-19 symptoms twelve months after hospitalisation in participants retained in follow-up: analyses stratified by gender from a large prospective cohort.
Auteur(s) :
Ghosn, J. [Auteur]
Bachelet, D. [Auteur]
Livrozet, M. [Auteur]
Cervantes-Gonzalez, M. [Auteur]
Poissy, Julien [Auteur]
Unité de Glycobiologie Structurale et Fonctionnelle (UGSF) - UMR 8576
Goehringer, F. [Auteur]
Gandonniere, C. S. [Auteur]
Maillet, M. [Auteur]
Bani-Sadr, F. [Auteur]
Martin-Blondel, G. [Auteur]
Tattevin, P. [Auteur]
Launay, O. [Auteur]
Surgers, L. [Auteur]
Dudoignon, E. [Auteur]
Liegeon, G. [Auteur]
Zucman, D. [Auteur]
Joseph, C. [Auteur]
Senneville, Eric [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Yelnik, Cécile [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Roger, P. M. [Auteur]
Faure, Karine [Auteur]
Centre d'Infection et d'Immunité de Lille (CIIL) - U1019 - UMR 9017
Gousseff, M. [Auteur]
Cabie, A. [Auteur]
Duval, X. [Auteur]
Chirouze, C. [Auteur]
Laouenan, Cédric [Auteur]
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Bachelet, D. [Auteur]
Livrozet, M. [Auteur]
Cervantes-Gonzalez, M. [Auteur]
Poissy, Julien [Auteur]
Unité de Glycobiologie Structurale et Fonctionnelle (UGSF) - UMR 8576
Goehringer, F. [Auteur]
Gandonniere, C. S. [Auteur]
Maillet, M. [Auteur]
Bani-Sadr, F. [Auteur]
Martin-Blondel, G. [Auteur]
Tattevin, P. [Auteur]
Launay, O. [Auteur]
Surgers, L. [Auteur]
Dudoignon, E. [Auteur]
Liegeon, G. [Auteur]
Zucman, D. [Auteur]
Joseph, C. [Auteur]
Senneville, Eric [Auteur]
METRICS : Evaluation des technologies de santé et des pratiques médicales - ULR 2694
Yelnik, Cécile [Auteur]
Centre Hospitalier Régional Universitaire [CHU Lille] [CHRU Lille]
Roger, P. M. [Auteur]
Faure, Karine [Auteur]
Centre d'Infection et d'Immunité de Lille (CIIL) - U1019 - UMR 9017
Gousseff, M. [Auteur]
Cabie, A. [Auteur]
Duval, X. [Auteur]
Chirouze, C. [Auteur]
Laouenan, Cédric [Auteur]
AP-HP - Hôpital Bichat - Claude Bernard [Paris]
Titre de la revue :
Clinical Microbiology and Infection
Nom court de la revue :
Clin Microbiol Infect
Numéro :
29
Pagination :
254.E7-254.E13
Éditeur :
Elsevier
Date de publication :
2022-10-04
ISSN :
1469-0691
Mot(s)-clé(s) en anglais :
Cohort
Emerging infectious diseases
Moderate to severe COVID-19
Post-acute COVID-19 symptoms
SARS-CoV-2
Emerging infectious diseases
Moderate to severe COVID-19
Post-acute COVID-19 symptoms
SARS-CoV-2
Discipline(s) HAL :
Sciences du Vivant [q-bio]
Résumé en anglais : [en]
Objectives
Persistent post-acute coronavirus disease 2019 (COVID-19) symptoms (PACSs) have been reported up to 6 months after hospital discharge. Herein we assessed the symptoms that persisted 12 months (M12) after admission ...
Lire la suite >Objectives Persistent post-acute coronavirus disease 2019 (COVID-19) symptoms (PACSs) have been reported up to 6 months after hospital discharge. Herein we assessed the symptoms that persisted 12 months (M12) after admission for COVID-19 in the longitudinal prospective national French coronavirus disease cohort. Methods Hospitalized patients with a confirmed virological diagnosis of COVID-19 were enrolled. Follow-up was planned until M12 after admission. Associations between persistence of ≥3 PACSs at M12 and clinical characteristics at admission were assessed through logistic regression according to gender. Results We focused on participants enrolled between 24 January 2020 and 15 July 2020, to allow M12 follow-up. The M12 data were available for 737 participants. Median age was 61 years, 475 (64%) were men and 242/647 (37%) were admitted to intensive care units during the acute phase. At M12, 27% (194/710) of the participants had ≥3 persistent PACS, mostly fatigue, dyspnoea and joint pain. Among those who had a professional occupation before the acute phase, 91 out of 339 (27%) were still on sick leave at M12. Presence of ≥3 persistent PACS was associated with female gender, both anxiety and depression, impaired health-related quality of life and Medical Muscle Research Council Scale <57. Compared with men, women more often reported presence of ≥3 persistent PACSs (98/253, 39% vs. 96/457, 21%), depression and anxiety (18/152, 12% vs. 17/268, 6% and 33/156, 21% vs. 26/264, 10%, respectively), impaired physical health-related quality of life (76/141, 54% vs. 120/261, 46%). Women had less often returned to work than men (77/116, 66% vs. 171/223, 77%). Conclusions One fourth of the individuals admitted to hospital for COVID-19 still had ≥3 persistent PACSs at M12 post-discharge. Women reported more often ≥3 persistent PACSs, suffered more from anxiety and depression and had less often returned to work than men.Lire moins >
Lire la suite >Objectives Persistent post-acute coronavirus disease 2019 (COVID-19) symptoms (PACSs) have been reported up to 6 months after hospital discharge. Herein we assessed the symptoms that persisted 12 months (M12) after admission for COVID-19 in the longitudinal prospective national French coronavirus disease cohort. Methods Hospitalized patients with a confirmed virological diagnosis of COVID-19 were enrolled. Follow-up was planned until M12 after admission. Associations between persistence of ≥3 PACSs at M12 and clinical characteristics at admission were assessed through logistic regression according to gender. Results We focused on participants enrolled between 24 January 2020 and 15 July 2020, to allow M12 follow-up. The M12 data were available for 737 participants. Median age was 61 years, 475 (64%) were men and 242/647 (37%) were admitted to intensive care units during the acute phase. At M12, 27% (194/710) of the participants had ≥3 persistent PACS, mostly fatigue, dyspnoea and joint pain. Among those who had a professional occupation before the acute phase, 91 out of 339 (27%) were still on sick leave at M12. Presence of ≥3 persistent PACS was associated with female gender, both anxiety and depression, impaired health-related quality of life and Medical Muscle Research Council Scale <57. Compared with men, women more often reported presence of ≥3 persistent PACSs (98/253, 39% vs. 96/457, 21%), depression and anxiety (18/152, 12% vs. 17/268, 6% and 33/156, 21% vs. 26/264, 10%, respectively), impaired physical health-related quality of life (76/141, 54% vs. 120/261, 46%). Women had less often returned to work than men (77/116, 66% vs. 171/223, 77%). Conclusions One fourth of the individuals admitted to hospital for COVID-19 still had ≥3 persistent PACSs at M12 post-discharge. Women reported more often ≥3 persistent PACSs, suffered more from anxiety and depression and had less often returned to work than men.Lire moins >
Langue :
Anglais
Audience :
Internationale
Vulgarisation :
Non
Établissement(s) :
Université de Lille
CHU Lille
CHU Lille
Date de dépôt :
2023-11-15T03:16:04Z
2024-05-15T09:58:11Z
2024-05-15T09:58:11Z